Dexibuprofen (S(+)-isomer ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents

Anesthesia and Analgesia

Volumn 97, Issue 2, 2003, Pages 402-408

  Bonabello, Angelo ^a   Galmozzi, M R ^a   Canaparo, R ^b   Isaia, G C ^c   Serpe, L ^b   Muntoni, E ^b   Zara, G P ^b  

^a Research Department   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DEXIBUPROFEN; HALOTHANE; IBUPROFEN; INHALATION ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIA; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; DRUG FORMULATION; GASTRITIS; HOT PLATE TEST; ISOMER; MALE; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL; RAT; STOMACH MUCOSA; TAIL FLICK TEST;

EID: 0041963056     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000073349.04610.42     Document Type: Article

References (26)

1. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97-120.
2. Warner TD, Giuliano F, Vojnovic I, et al. No steroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999;96:7563-8.
3. Bonenberg E, Zou M-H, Ullrich V. Inhibition of cyclooxygenase-1 and -2 by R(-) and S(+)-ibuprofen. J Clin Pharmacol 1996;36:16S-9.
4. Young JM, Panah S, Satchawatcharaphong C, et al. Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production. Inflamm Res 1996;45:246-53.
5. Brideau C, Kargman S, Liu S, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res 1996;45:68-72.
6. Wechter JW, Loughhaed DG, Reischer RJ, et al. Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R(-) p-iso-butyl hydrotropic acid. Biochem Biophys Res Commun 1974;61:833-7.
7. Caldwell J, Hutt AJ, Fournel-Gigleux S. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem Pharmacol 1988;37:105-14.
8. Williams KM. Enantiomers in arthritic disorders. Pharmacol Ther 1990;46:273-95.
9. Greennan DM, Aarons L, Siddiqui M, et al. Dose-response study with ibuprofen in rheumatoid arthritis: clinical and pharmacokinetic findings. Br J Clin Pharmacol 1983;15:311-6.
10. Laska EM, Williams K, Day R, et al. The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther 1986;40:1-7.
11. Simon LC, Weaver AL, Graham DY, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA 1999;282:1921-8.
12. Wallace JL, McKnight W, Reuter BK, et al. NSAID-induced gastric damage in rats: requirements for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 2000;119:706-14.
13. Dionne RA, McCullagh L. Enhanced analgesia and suppression of plasma β-endorphin by the S(+)-isomer of ibuprofen. Clin Pharmacol Ther 1998;63:694-701.
14. Arendt-Nielsen L, Nielsen J, Petersen-Felix S, et al. Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain. Br J Anaesth 1996;77:625-31.
15. O'Callaghan JP, Holtzman SG. Quantitation of the analgesic activity of narcotic antagonists by a modified hot plate procedure. J Pharmacol Exp Ther 1975;192:497-505.
16. D'Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941;72:74-9.
17. Dewey WL, Harris LS, Howes JF, Nuite JA. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther 1970;175:435-42.
18. Hendershot LC, Forsaith J. Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and non-analgesics. J Pharmacol Exp Ther 1959;125:237-40.
19. Winter CA, Risley EA, Nuss GW. Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962;111:544-9.
20. Planas ME, Sanchez S, Gonzalez P, et al. Protective effect of fructose 1,6-bisphosphonate against carrageenan-induced inflammation. Eur J Pharmacol 1993;237:251-5.
21. Geisslinger G, Schuster O, Stock KP, et al. Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis. Eur J Pharmacol 1990;38:493-7.
22. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992;263:136-46.
23. Malmberg AB, Yaksh TL. Antinociceptive produced by spinal delivery of the S and R-enantiomers of flurbiprofen in the formalin test. Eur J Pharmacol 1994;256:205-9.
24. Neugebauer V, Geiss G, Rumenapp P, et al. Antinociceptive effects for R(-)- and S(+)-flurbiprofen on rat spinal dorsal horn neurones rendered hyperexcitable by acute knee joint inflammation. J Pharmacol Exp Ther 1995;275:618-28.
25. Mayer JM, Testa B. Pharmacodynamic, pharmacokinetics and toxicity of ibuprofen enantiomers. Drugs of the Future 1997;22:1347-66.
26. Laudano OM, Cesolari JA, Esnarriaga J, et al. In vivo selectivity of nonsteroidal anti-inflammatory drugs and gastrointestinal ulcers in rats. Dig Dis Sci 1999;45:1359-65.